Approaches for understanding and predicting drug interactions in human immunodeficiency virus-infected patients

By Jiméénez-Náácher Inmaculada   Alvarez Elena   Morello Judit   Rodriguez-Nóóvoa Sonia   de Andréés Susana   Soriano Vincent  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 7, Iss. 4, 2011-04 ,pp. : 457-477

Informa Healthcare

Access to resources Recommend Favorite

Emerging Drug Toxicities of Highly Active Antiretroviral Therapy for HumanImmunodeficiency Virus (HIV) Infection

By  

Current Drug Targets, Vol. 4, Iss. 1, 2003-01 ,pp. : 13-22

Bentham Science Publishers

Access to resources Recommend Favorite

Drug Interactions Between Antiretroviral Drugs and Comedicated Agents

By de Maat M.M.R.  

Clinical Pharmacokinetics, Vol. 42, Iss. 3, 2003-01 ,pp. : 223-282

Adis International

Access to resources Recommend Favorite

Antiretroviral Therapy Does Not Block the Secretion of the Human Immunodeficiency Virus Tat Protein

By  

Infectious Disorders - Drug Targets (Formerly Current Drug Targets - Infectious Disorders), Vol. 12, Iss. 1, 2012-02 ,pp. : 81-86

Bentham Science Publishers

Access to resources Recommend Favorite

Drug–drug interactions and tolerance in combining antituberculosis and antiretroviral therapy

By Di Perri Giovanni   Aguilar Marucco Diego   Mondo Alessandra   Gonzalez de Requena Daniel   Audagnotto Sabrina   Gobbi Federico   Bonora Stefano  

Expert Opinion on Drug Safety, Vol. 4, Iss. 5, 2005-09 ,pp. : 821-836

Informa Healthcare

Access to resources Recommend Favorite